Category | Controls | Post-BOS | Pre-BOS1–15 | Pre-BOS16–76 |
---|---|---|---|---|
Samples (N) | 48 | 17 | 32 | 27 |
Individuals (N) | 28 | 8 | 15 | 18 |
Female (%) | 48 | 50 | 53 | 59 |
Age (Avg ± STD) | 44.8 ± 9.1 | 51.9 ± 9.7 | 47.7 ± 9.0 | 47.2 ± 9.5 |
Month_After_TX (Avg ± STD) | 12 ± 12 | 26 ± 17 | 16 ± 18 | 7 ± 5 |
Reasons for transplant [34] | ||||
Alpha-1–antripysin deficiency | 6 | 3 | 3 | 3 |
Bronchiectasis | 1 | |||
COPD/emphysema | 9 | 2 | 5 | 4 |
Cystic fibrosis | 5 | 1 | ||
Primary pulmonary hypertension | 2 | 1 | 5 | |
Eisenmenger’s syndromes | 2 | 2 | 1 | |
Idiopathic pulmonary fibrosis | 1 | 1 | 1 | 1 |
Obliterative bronchiolitis | 1 | 1 | ||
Lung Re-Tx | 1 | 2 | 1 | |
Not defined | 1 | 1 | 2 |